Clinical validation of superior vena cava respiratory variation in predicting fluid responsiveness using transthoracic echocardiography technique: a pilot study
Qian Ma(Peking University Shenzhen Hospital), Bingbing Li(Nanjing Drum Tower Hospital), Lu Xu(Nanjing Drum Tower Hospital), Jingjing Ji(Third Affiliated Hospital of Southern Medical University), Ziyun Lu(Nanjing Drum Tower Hospital), Xueduo Shi(Nanjing Drum Tower Hospital), Jing Hao(Capital Medical University), Wei Zhu(Ministry of Education of the People's Republic of China)
Cited by 2
Related Papers
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway
|Annals of the Rheumatic Diseases|2011|412
Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases
|PLoS ONE|2012|196
A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients
|Annals of the Rheumatic Diseases|2013|168